Market Closed -
Other stock markets
|
Pre-market 09:10:32 am | |||
127.6 USD | +0.04% | 127 | -0.42% |
May. 02 | Merck: encouraging results in gastric cancer | CF |
May. 01 | Merck Says Keytruda Meets Primary Endpoint in Late-Stage Gastric Cancer Trial | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.02% | 323B | |
+31.52% | 690B | |
+25.10% | 546B | |
-5.21% | 358B | |
+5.01% | 287B | |
+14.06% | 235B | |
+5.27% | 199B | |
-9.98% | 195B | |
+3.98% | 161B | |
-2.19% | 159B |
- Stock Market
- Equities
- MRK Stock
- News Merck & Co., Inc.
- Cantor Fitzgerald Adjusts Merck & Co.' Price Target to $155 From $135, Keeps Overweight Rating